Moneybags

QUESTIONS OVER UDG’S DISASTROUS SELL-OFF

Date: March 7, 2019 - Moneybags

Brendan McAtamney

Brendan McAtamney


LAST YEAR it was almost impossible to decipher the results for UDG Healthcare (previously United Drug) and, this year, the damage done to the group by a disastrous sell-off has again been well disguised. There are serious questions to be asked about the sale of UDG’s Aquilant subsidiary, which resulted in a loss of $100m…. Read more »

To access this content, you must be a Phoenix subscriber.

Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!

Subscribe Now! I'm a Subscriber